Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enthesitis-Related Arthritis, Juvenile”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Large-scale testing (Phase 3)Study completedNCT01421069
What this trial is testing

Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Who this might be right for
Juvenile Idiopahtic Arthritis
Pfizer 109
Large-scale testing (Phase 3)Looking for participantsNCT03773965
What this trial is testing

Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 190
Large-scale testing (Phase 3)Active Not RecruitingNCT05083182
What this trial is testing

Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

Who this might be right for
Arthritis, Juvenile
Janssen Research & Development, LLC 50
Large-scale testing (Phase 3)Study completedNCT01166282
What this trial is testing

The Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis

Who this might be right for
Enthesitis Related Arthritis (ERA)
AbbVie (prior sponsor, Abbott) 46
Large-scale testing (Phase 3)Looking for participantsNCT06663332
What this trial is testing

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Who this might be right for
Crohns DiseaseColitis, UlcerativeArthritis, Psoriatic+1 more
Janssen Research & Development, LLC 196
Large-scale testing (Phase 3)Study completedNCT03769168
What this trial is testing

An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)

Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis Related Arthritis
Novartis Pharmaceuticals 55
Not applicableLooking for participantsNCT06383195
What this trial is testing

The Reliability and Validity of the Ankylosing Spondylitis Performance Index (ASPI) in Enthesitis-Related Arthritis

Who this might be right for
Enthesitis Related ArthritisEnthesitis Related Arthritis, Juvenile
Hacettepe University 40
Large-scale testing (Phase 3)Looking for participantsNCT06100744
What this trial is testing

Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

Who this might be right for
Juvenile Psoriatic Arthritis
AbbVie 40
Large-scale testing (Phase 3)Ended earlyNCT01230827
What this trial is testing

The Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

Who this might be right for
Juvenile Idiopathic Arthritis
Janssen Research & Development, LLC 173
Not applicableStudy completedNCT03858504
What this trial is testing

Yoga Versus Home Exercise Program in Children With Enthesitis Related Arthritis

Who this might be right for
Enthesitis Related Arthritis
Pamukkale University 21
Large-scale testing (Phase 3)Study completedNCT00962741
What this trial is testing

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Who this might be right for
Arthritis, Juvenile Idiopathic
Pfizer 127
Not applicableNot Yet RecruitingNCT06431750
What this trial is testing

Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 150
Large-scale testing (Phase 3)Looking for participantsNCT05767047
What this trial is testing

Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis

Who this might be right for
Behçet's DiseaseJuvenile Psoriatic Arthritis
Amgen 48
Not applicableNot Yet RecruitingNCT06766552
What this trial is testing

A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.

Who this might be right for
Ankylosing Spondylitis (AS)Psoriatic Arthritis (PsA)Nr-axSpA+5 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 10,000
Early research (Phase 1)Looking for participantsNCT06751238
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

Who this might be right for
Juvenile Psoriatic Arthritis
Novartis Pharmaceuticals 20
Early research (Phase 1)Study completedNCT06291948
What this trial is testing

A Clinical Study With Adalimumab Biosimilar

Who this might be right for
PharmacokineticsSafety Issues
Laboratorios Richmond S.A.C.I.F. 150
Not applicableNot Yet RecruitingNCT07190053
What this trial is testing

Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.

Who this might be right for
Enthesitis-related Arthritis (ERA)Juvenile Psoriatic Arthritis (JPsA)
Novartis Pharmaceuticals 100
Large-scale testing (Phase 3)Study completedNCT03031782
What this trial is testing

Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)

Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis-related Arthritis
Novartis Pharmaceuticals 86
Large-scale testing (Phase 3)Study completedNCT03773978
What this trial is testing

Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 220
Not applicableLooking for participantsNCT02418442
What this trial is testing

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Who this might be right for
Rheumatic Joint Disease
Duke University 20,000
Load More Results